Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F373280 to maintain sinus rhythm after cardioversion in atrial fibrillation with chronic heart failure
2012-003487-48Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of F373280 in Atrial fibrillation (AFib) and chronic heart failure (CHF), sponsored by Pierre Fabre Laboratories. Primary endpoint: efficacy. Started Dec 2012; status: completed.
02
Drugs
F373280
03
Conditions
Atrial fibrillation (AFib)chronic heart failure (CHF)
Beyond the preview
Go deeper on 2012-003487-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003487-48.